The unexpected situation we are facing has strongly break the clinical research rules. Nevertheless, for the scientific community, it may represent the opportunity to learn important lessons. Clinical Research industry breaks in post covid-19 era. will some rules be change ?The COVID-19 pandemic suggests that it is possible to alleviate break in clinical trials, and while preserving the efficient of a study, can offer a new, less burdened and more inclusive vision of clinical research for the scientific community of tomorrow. This perspective article describes clinicians’ vision of how the pandemic could change the roles of clinical research.
Since the beginning of the SARS-COV2 outbreak in Wuhan, more than 24 million people have been infected all around the world and more than 800 000 have died from the disease so far. In this scenario, Europe is facing one of the worst crises that our National Health Systems have ever encountered in the last 50 years. Six months after the first COVID-19 diagnosis, the lockdown is being eased in European countries and our lives are slowly adapting to ‘a new normality’.
Can people adapt with the new normal or this is against the law of nature that viruses are also the organisms lead life in nature . For more details contact Agatha School of Skill Development SINCE 2008 mail us on https://qicsd.com